PROS1 and COVID-19: Here, we demonstrated that while routine coagulation blood testing (d-dimer, free protein S and fibrinogen) could distinguish between COVID-19 patients and HCs, these tests were not able to distinguish between the three levels of clinical COVID-19 patients’ disease severity.